Loading insider details...
Beta
Latest Form 4 (Mar 9, 2026): Purchase of 7,000 ADMA shares, $109.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 9, 2026 | ADMA BIOLOGICS, INC. (ADMA) | Purchase | 7,000 | $109.7K |
| Feb 12, 2026 | ADMA BIOLOGICS, INC. (ADMA) | Grant/Award | 10,690 | n/a |
| Nov 19, 2025 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 84,411 | n/a |
| Jun 17, 2025 | ADMA BIOLOGICS, INC. (ADMA) | Sale | 92,941 | $2.02M |
| Feb 22, 2025 | ADMA BIOLOGICS, INC. (ADMA) | Grant/Award | 10,889 | n/a |
| Feb 14, 2025 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 30,000 | n/a |
| Dec 26, 2024 | Marker Therapeutics, Inc. (MRKR) | Purchase | 11,085 | $35.5K |
| Dec 3, 2024 | ADMA BIOLOGICS, INC. (ADMA) | Exercise/Conversion | 9,000 | $97.2K |
| Jun 17, 2024 | Elevation Oncology, Inc. (ELEV) | Grant/Award | 35,000 | n/a |
| Mar 20, 2024 | ADMA BIOLOGICS, INC. (ADMA) | Sale | 49,887 | $299.8K |